Molecule Details
InChIKeyZIQFYVPVJZEOFS-UHFFFAOYSA-N
Compound NamePD-166326
Canonical SMILESCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)9
Pfam Stratification Cross-Family
Avg pChEMBL7.5
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB08339
Drug NamePD-166326
CAS Number185039-91-2
Groups experimental
ATC Codes nan
Descriptionnan

Cross-references: BindingDB: 3085 CHEMBL327127 ChemSpider: 394719 PDB: P16 PubChem:447700 PubChem:99444810 ZINC: ZINC000002047503
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
P00519 ABL1 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 8.6 IC50 ChEMBL;BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 8.4 pIC50 TTD_MultiTarget
P11362 FGFR1 Homo sapiens Human PF07679 PF00047 PF07714 8.2 pIC50 TTD_MultiTarget
P12931 SRC Homo sapiens Human PF07714 PF00017 PF00018 8.2 IC50 ChEMBL;BindingDB
P16234 PDGFRA Homo sapiens Human PF07679 PF25305 PF07714 7.1 IC50 ChEMBL
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.1 IC50 ChEMBL;BindingDB
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 6.9 IC50 ChEMBL;BindingDB
Q16539 MAPK14 Homo sapiens Human PF00069 6.8 IC50 ChEMBL;BindingDB
P10721 KIT Homo sapiens Human PF00047 PF07714 6.2 IC50 ChEMBL;BindingDB
DrugBank Target Actions (9)
Target Gene Target Name Action Type
P00519 ABL1 Tyrosine-protein kinase ABL1 inhibitor targets
P00533 EGFR Epidermal growth factor receptor inhibitor targets
P06239 LCK Tyrosine-protein kinase Lck inhibitor targets
P09619 PDGFRB Platelet-derived growth factor receptor beta inhibitor targets
P10721 KIT Mast/stem cell growth factor receptor Kit inhibitor targets
P11362 FGFR1 Fibroblast growth factor receptor 1 inhibitor targets
P12931 SRC Proto-oncogene tyrosine-protein kinase Src inhibitor targets
P16234 PDGFRA Platelet-derived growth factor receptor alpha inhibitor targets
Q16539 MAPK14 Mitogen-activated protein kinase 14 inhibitor targets